PGY2 Oncology Pharmacy Residency

The Division of Pharmacy at The University of Texas MD Anderson Cancer Center offers an ASHP accredited one-year PGY2 residency hematology/oncology. The Cancer Center has 600+ inpatient beds and over 3500 outpatient clinic visits daily. The residency program is heavily weighted in patient care activities designed to develop expertise and clinical competence in pharmacotherapeutic aspects of acute and ambulatory cancer. Through required and elective rotations in a variety of focused hematology/oncology services, the resident will refine his/her clinical problem-solving skills in cancer management and supportive care. This training will prepare the resident to provide comprehensive clinical pharmacy services to the oncology population and to investigate therapeutic questions related to the care of cancer patients. Under the direction of Andrea Landgraf, Pharm.D, BCOP, and the clinical pharmacy staff at MD Anderson, the resident will:

Provide comprehensive, pharmacotherapeutic patient management as a member of the following teams:
- Adult Leukemia
- Stem Cell Transplant
- Gastrointestinal Oncology
- Gynecologic Oncology
- Lymphoma/Myeloma
- Breast Medical Oncology
- Thoracic Oncology
- Genitourinary Oncology
- Infusion Center
- Palliative Care Elective
- Pediatric Heme/Onc Elective
- Other Electives

Participate in oncology-focused Drug Information and Drug Use Policy
Provide education to patients, pharmacy staff, medical and nursing staff, and pharmacy students
Participate in clinical research and Investigational Pharmacy Services
Refine presentation and publication skills

Program Director

Andrea Landgraf Oholendt, Pharm.D., BCOP
Director, PGY2 Oncology Pharmacy Residency
Division of Pharmacy
The University of Texas
MD Anderson Cancer Center
1515 Holcombe Blvd. – Unit 90
Houston, TX. 77030-4009

Telephone: 713-792-4552
E-mail: anlandgr@mdanderson.org